Avomeen's pharmaceutical testing laboratory answers the need for an independent, FDA-Registered, DEA-Licensed, cGMP-Compliant laboratory to provide accurate and timely analysis of pills, liquids, capsules and more.
Ann Arbor, Michigan (PRWEB) June 04, 2013
Since last fall’s deadly meningitis outbreak, Avomeen's pharmaceutical testing laboratory has dedicated new resources and developed new methods for the analysis of drugs from compounding pharmacies.
Compounding pharmacies pose a continued threat to consumers due to a lack of regulation by the Food and Drug Administration. FDA officials have recently released results from an inspection of 30 compounding pharmacies that mix sterile drugs. The results exposed dozens of safety problems including contaminates in the form of unidentified black particles bring found in vials of sterile solutions, rust/ mold within the manufacturing plants and workers being exposing to conditions that would allow their skin to come in contact with chemicals.
Pharmaceuticals mixed in conditions such as those confirmed by the FDA have a higher likelihood of contamination and subsequent detrimental effects when consumed. Avomeen's pharmaceutical testing laboratory answers the need for an independent, FDA-Registered, DEA-Licensed, cGMP-Compliant laboratory to provide accurate and timely analysis of pills, liquids, capsules and more.
Avomeen’s pharmaceutical testing division has bolstered its analytical capabilities by hiring additional senior scientists with backgrounds in areas such as deformulation, stability testing, quality control analysis and contamination identification. Avomeen is dedicated to the analysis of drugs and pills produced from compounding pharmacies.
New and enhanced services include impurity analysis, batch-to-batch testing, degradation profiling, trace metals analysis and contamination quantification. The pharmaceutical analysis staff now has the capability of efficiently and effectively analyzing the output of pills, liquids and drugs from compounding pharmacies.
To contact Avomeen to analyze a drug product from a compounding pharmacy call 800-930-5450 or email scientist (at) avomeen (dot) com
April 11th, 2013
FDA Food & Drug Administration
Proactive Inspections Further Highlight Need for New Authorities for Pharmacy Compounding